The RANK receptor and its ligand RANKL are factors involved in bone metabolism [94,95] and have also been widely described in the literature as significant factors in the carcinogenesis of many malignant tumors being detected in the tumor microenvironment [95]. Here, TNFSF11 is linked to cancer.